Abstract: An aza-ergoline derivative and a preparation method therefor and an application thereof. The derivative has a structure as shown in formula (I). The aza-ergoline derivative has good affinity, agonistic activity or selectivity to a dopamine D2 receptor.

Abstract: A display panel (10) includes a circuit backplane (1) and a reflective layer (3). The circuit backplane (1) includes a first main surface (11), a second main surface (12), and a plurality of side surfaces (13). The second main surface (12) is disposed opposite to the first main surface (11). The side surfaces (13) each connect the first main surface (11) and the second main surface (12). At least one side surface in the plurality of side surfaces (13) is a selected side surface (13a). The selected side surface (13a) is covered by the reflective layer (3), the reflective layer (3) being configured to be removed under a predetermined process condition.

Abstract: Aspects of the invention include detecting an error alert from a target computer system. In response to detecting the error alert, performance data is then retrieved from the target computer system. A gated recurrent unit (GRU) neural network is used to generate a prediction of a root cause of the error alert based on the performance data. The weights of a reset gate of the GRU neural network are adjusted based on received feedback of the prediction.

Abstract: Provided herein are novel CLDN6 binding domains, and anti-CLDN6×anti-CD3 antibodies that include such CLDN6 binding domains. Also provided herein are methods of using such antibodies for the treatment of CLDN6-associated cancers.

Abstract: Provided herein are novel CLDN6 binding domains, and anti-CLDN6×anti-CD3 antibodies that include such CLDN6 binding domains. Also provided herein are methods of using such antibodies for the treatment of CLDN6-associated cancers.

Abstract: In a network constructed according to a network planning parameter, access scheduling is performed on a User Equipment UE in accordance with a type of a service of the UE; statistics on an indicator of performing access scheduling on the UE are acquired; and it is determined whether the indicator meets a requirement in network capacity planning; and when the indicator meets the requirement, a target planning parameter is determined as the network planning parameter; otherwise when the indicator does not meet the requirement, the network planning parameter is adjusted until the indicator meets the requirement in network capacity planning. Network capacity for multiple services is planned according to service features, improving accuracy of network capacity planning.

Abstract: A transparent or translucent cosmetic composition in the form of a water-in-oil emulsion is provided. The composition includes an aqueous phase at a concentration, by weight, of about 50%-90%, based upon weight of the composition. The aqueous phase includes at least one amphiphilic compound selected from the group consisting of urea, sodium 5-oxo-2-pyrrolidinecarboxylate (sodium PCA), hydroxyethyl urea, nicotinamide, sodium citrate, ascorbic acid, or combinations thereof. The at least one amphiphilic compound is at a concentration, by weight, of about 2% to about 50%, based upon weight of the composition. The composition includes an oil phase comprising at least one water-in-oil emulsifier at a concentration, by weight, of about 1%-25%, based upon weight of the composition. The water-in-oil emulsion is a transparent or translucent composition.

Abstract: An ionization vacuum gauge includes a cathode, an anode and an ion collector. The ion collector component is located at one side of the anode component and spaced from the anode component. The cathode component is located at another side of the anode component and includes an electron emitter, which extends toward the anode component from the cathode component. The electron emitter includes at least one carbon nanotube wire.

Abstract: Disclosed are a capacity planning method and device for a wireless broadband network. The method comprises: in a network constructed based on a current network planning parameter that needs to be determined, granting UEs access and scheduling the UEs according to service types of the UEs; making statistics on an index result about the access granting and scheduling on the UEs; and determining whether the index result satisfies a network capacity planning requirement; if yes, determining the current network planning parameter as a target planning parameter; otherwise, adjusting the network planning parameter until the index result about the access granting and scheduling of the UEs satisfies the network capacity planning requirement. The present invention plans network capacity for multiple services according to service features, and improves accuracy of the network capacity planning.

Abstract: A method for optimizing the configuration of a distributed CCHP system is disclosed.

Abstract: Disclosed herein are materials and methods for sensitizing multidrug resistant cancer cells that express ABCG2 and related proteins members of a family of ATP-binding transporter superfamily that mediate drug efflux found in some types of multidrug resistant cancer cells. A series of compounds, including (N-(4-chlorophenyl)-2-[(6-{[4,6-di(4-morpholinyl)-1,3,5-tri-azin-2-yl]amino}-1,3-benzothiazol-2-yl)sulfanyl]acetamide), specifically inhibits ABCG2 and can be used to boost the bio-avail-ability of one or more effective cancer killing drugs, making it possible to use certain widely used chemotherapeutic reagent to treat multidrug resistance cancers. Using these compounds in combination with chemotherapeutic drugs that are substrates for ABCG2 and related proteins may also find utility in treating cancer cells that are not currently identified as multi-drug resistant. Additionally, these compounds appear to accelerate the intercellular degradation of ABCG2 and related proteins.

Abstract: An ionization vacuum gauge includes a cathode, an anode and an ion collector. The ion collector component is located at one side of the anode component and spaced from the anode component. The cathode component is located at another side of the anode component and includes an electron emitter, which extends toward the anode component from the cathode component. The electron emitter includes at least one carbon nanotube wire.

Abstract: An exemplary liquid crystal display (LCD) (200) includes an LCD panel having a plurality of display regions (240) arranged sequentially; a plurality of gate driving circuit (250) respectively connected to the display regions for providing scan signal to scanning the display region; at least a data driving circuit (230) for generating gradation voltages and providing the gradation voltages to the corresponding scanned display region; and a delay control circuit connected between the data driving circuit and the display regions for delaying the gradation voltages provided to each display region. The sum of the first delay value generated by the delay control circuit when the gradation voltages are applied to one of the display regions and the second delay value of the same gradation voltages being generated when the gradation voltages are transmitted from the gate driving circuit to the same one of the display regions is approximately constant for all of the display regions.

Abstract: A backlight driving circuit includes a light driving unit, which includes a constant current unit, and a light source operated by the constant current unit. The light driving unit further includes a feedback control unit and a detection circuit. The detection circuit detects the light source and outputs at least a voltage feedback signal to the feedback control unit. The feedback control unit obtains a prestored power parameter corresponding to the voltage feedback signal and outputs an adjusting signal to the constant current unit to adjust the constant current of the light source.

Abstract: Disclosed herein are materials and methods for sensitizing multidrug resistant cancer cells that express ABCG2 and related proteins members of a family of ATP-binding transporter superfamily that mediate drug efflux found in some types of multidrug resistant caner cells. A series of compounds, including (N-(4-chlorophenyl)-2-[(6-{[4,6-di(4-morpholinyl)-1,3,5-tri-azin-2-yl]amino}-1,3-benzothiazol-2-yl)sulfanyl]acetamide), specifically inhibits ABCG2 and can be used to boost the bio-avail-ability of one or more effective cancer killing drugs, making it possible to use certain widely used chemotherapeutic reagent to treat multidrug resistance cancers. Using these compounds in combination with chemotherapeutic drugs that are substrates for ABCG2 and related proteins may also find utility in treating cancer cells that are not currently identified as multi-drug resistant Additionally, these compounds appear to accelerate the intercellular degradation of ABCG2 and related proteins.

Abstract: An exemplary liquid crystal display (200) includes a liquid crystal panel, a gate driving circuit (210), and a data driving circuit (220). The liquid crystal panel includes a pixel array (230), a short-circuit test circuit (240), and a control circuit (290). The short-circuit test circuit and the control circuit cooperatively form a discharging circuit. When the liquid crystal display is powered off, electric charge stored in the liquid crystal panel is discharged through the discharging circuit. The gate driving circuit is configured for scanning the liquid crystal panel. The data driving circuit is configured for providing gray-scale voltages to the liquid crystal panel when the liquid crystal panel is scanned.